Corti, Manuela
University of Florida Health · University of Florida
9 papers on CoChatORCID 0000-0002-6391-4139
Most cited papers
- Verified
Current clinical applications of in vivo gene therapy with AAVs
Mendell, J. R., Al-Zaidy, S. A., Rodino-Klapac, L. R., Goodspeed, K., Gray, S. J., Kay, C. N., Boye, S. L., Boye, S. E., George, L. A., Salabarria, S., et al. (2021) · Molecular Therapy
Virus-based gene therapy researchNeurogenetic and Muscular Disorders Research
Cited by 743
- Verified
Thrombotic microangiopathy following systemic AAV administration is dependent on anti-capsid antibodies
Salabarria, S. M., Corti, M., Coleman, K. E., Wichman, M. B., Berthy, J. A., D’Souza, P., Tifft, C. J., Herzog, R. W., Elder, M. E., Shoemaker, L. R., et al. (2024) · Journal of Clinical Investigation
Virus-based gene therapy researchComplement system in diseases
Cited by 159
- Verified
B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study
Corti, M., Elder, M., Falk, D., Lawson, L., Smith, B., Nayak, S., Conlon, T., Clément, N., Erger, K., Lavassani, E., et al. (2014) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchLysosomal Storage Disorders Research
Cited by 140
- Verified
Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV- hGAA ) Gene Therapy in Children Affected by Pompe Disease
Corti, M., Liberati, C., Smith, B. K., Lawson, L. A., Tuna, I. S., Conlon, T. J., Coleman, K. E., Islam, S., Herzog, R. W., Fuller, D. D., et al. (2017) · Human Gene Therapy Clinical Development
Lysosomal Storage Disorders ResearchVirus-based gene therapy research
Cited by 120
- Verified
Management of neuroinflammatory responses to AAV-mediated gene therapies for neurodegenerative diseases
Perez, B. A., Shutterly, A., Chan, Y. K., Byrne, B. J., & Corti, M. (2020) · Brain Sciences
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 112
- Verified
Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy
Byrne, B. J., Fuller, D. D., Smith, B. K., Clement, N., Coleman, K., Cleaver, B., Vaught, L., Falk, D. J., McCall, A., & Corti, M. (2019) · Annals of Translational Medicine
Lysosomal Storage Disorders ResearchGlycogen Storage Diseases and Myoclonus
Cited by 51
- Verified
B cell focused transient immune suppression protocol for efficient AAV readministration to the liver
Rana, J., Herzog, R. W., Muñoz-Melero, M., Yamada, K., Kumar, S. R. P., Lam, A. K., Markusic, D. M., Duan, D., Terhorst, C., Byrne, B. J., et al. (2024) · Molecular Therapy - Methods & Clinical Development
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 26
- Verified
Considerations for Systemic Use of Gene Therapy
Byrne, B. J., Corti, M., & Muntoni, F. (2021) · Molecular Therapy
Virus-based gene therapy researchRNA Interference and Gene Delivery
Cited by 23
- Verified
Altered activation of the tibialis anterior in individuals with Pompe disease: Implications for motor unit dysfunction: Neuromuscular Activation in Pompe
Corti, M., Smith, B. K., Falk, D. J., Lawson, L. A., Fuller, D. D., Subramony, S. H., Byrne, B. J., & Christou, E. A. (2015) · Muscle & Nerve
Lysosomal Storage Disorders ResearchMuscle Physiology and Disorders
Cited by 20
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free